If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
455.00    18.00 (4.12%)
Bid:
453.00
Ask:
459.00
Spread: 6.00 (1.325%)
Market Cap: £223.78m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Re Agreement

21 Mar 2006 14:37

Zotefoams PLC21 March 2006 21 March 2006 Commercial agreement between Zotefoams plc ("Zotefoams") and Sekisui ChemicalCompany Limited and its subsidiaries ("Sekisui Group") With immediate effect, Zotefoams and Sekisui Group have agreed to terminatetheir commercial agency relationships in Europe and North America. Sekisui willcontinue to act as distributor for Zotefoams' products in Asia until 30 April2006. During 2000 and 2001 Zotefoams entered into a number of worldwide sales andmarketing alliances for polyolefin foams with Sekisui Group, who act asexclusive agent and distributor for Zotefoams in Continental Europe (throughtheir European subsidiary, Alveo AG ("Alveo")) and Asia respectively. SekisuiGroup also act as an agent for certain of Zotefoams' customers in North Americathrough its American subsidiary, Voltek LLC. On 15 December 2005 and on 14 March 2006, Zotefoams announced that it had, forsome time, been in negotiations with Sekisui Group in relation to certain of itsobligations under two of these agreements. Zotefoams announced that while it wasstill open to a resolution by other means, it had instigated arbitrationproceedings. Termination of these arrangements was agreed subject to Zotefoams plc payingAlveo a reduced termination fee of euro 1.4 million as well as dropping alldisputes due to be heard in arbitration. Zotefoams will assume directresponsibility for all customer matters in all regions with plans to increasedirect sales resource to support this, although it is envisaged separateagreements may be appropriate in Asia in the medium term. In 2005, Zotefoams paid Sekisui Group approximately euro 1.5 million in agent'scommissions (principally to Alveo) under these arrangements. From 20 March 2006,no further commissions will be earned by Sekisui Group. Zotefoams is pleased that these disputes have been resolved with Sekisui andlooks forward to working directly with its customers. Enquiries: Zotefoams plc 0208-664-1600David Stirling, Managing DirectorClifford Hurst, Finance Director Financial Dynamics Limited 0774-602-739 / 0207-831-3113Sarah MacLeod / Deborah Scott This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jun 20192:53 pmRNSDirector/PDMR Shareholding
4th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20193:06 pmRNSDirector/PDMR Shareholding
28th May 201911:54 amRNSHolding(s) in Company
28th May 20199:38 amRNSHolding(s) in Company
21st May 20195:36 pmRNSDirector/PDMR Shareholding
21st May 201912:20 pmRNSHolding(s) in Company
20th May 20197:00 amRNSHolding(s) in Company
16th May 201912:46 pmRNSDirector/PDMR Shareholding
15th May 20193:51 pmRNSResult of AGM
15th May 20197:00 amRNSTrading Update
7th May 20199:11 amRNSDirector Declaration
25th Apr 20194:40 pmRNSDirector/PDMR Shareholding
17th Apr 20192:35 pmRNS2018 Annual Report and Notice of the 2019 AGM
16th Apr 20194:41 pmRNSDirector/PDMR Shareholding
12th Apr 20193:54 pmRNSDirector/PDMR Shareholding
4th Apr 201911:01 amRNSHolding(s) in Company
29th Mar 201912:57 pmRNSHolding(s) in Company
22nd Mar 20192:21 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
18th Mar 20194:12 pmRNSHolding(s) in Company
14th Mar 201911:46 amRNSDirector/PDMR Shareholding
5th Mar 20195:55 pmRNSDirector Declaration
14th Feb 20195:02 pmRNSDirector/PDMR Shareholding
28th Jan 20195:09 pmRNSHolding(s) in Company
28th Jan 20197:00 amRNSNotice of Results
15th Jan 20195:08 pmRNSDirector/PDMR Shareholding
15th Jan 20192:06 pmRNSHolding(s) in Company
9th Jan 20193:48 pmRNSHolding(s) in Company
7th Jan 201911:41 amRNSHolding(s) in Company
7th Jan 201911:37 amRNSHolding(s) in Company
7th Jan 201910:37 amRNSHolding(s) in Company
7th Jan 201910:33 amRNSHolding(s) in Company
19th Dec 20189:11 amRNSHolding(s) in Company
13th Dec 20181:16 pmRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 20185:26 pmRNSHolding(s) in Company
19th Nov 20185:37 pmRNSHolding(s) in Company
13th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:30 amRNSHolding(s) in Company
7th Nov 201812:50 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTrading Update
12th Oct 20185:06 pmRNSDirector/PDMR Shareholding
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company
15th Aug 201811:53 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.